SS&C Technologies
SSNC
$73.88
+10.35%
SS&C Technologies provides software products and software-enabled services to financial services clients, including portfolio management, fund administration, and trading solutions. As a market leader in financial technology, the company has grown through strategic acquisitions such as DST Systems, Intralinks, and Blue Prism, creating a diversified platform spanning asset management, healthcare, and virtual deal rooms. The current investor narrative centers on the company's ability to sustain mid-single-digit organic revenue growth while integrating acquisitions and expanding margins, with recent quarterly results showing 8.8% YoY revenue growth and improving profitability.…
SSNC
SS&C Technologies
$73.88
Investment Opinion: Should I buy SSNC Today?
Rating: Buy. The thesis is that SSNC's improving margins, strong free cash flow, and discounted forward valuation provide a favorable risk/reward, with 33.7% upside to the average analyst target of $93.00. The consensus analyst rating is Buy (mean 1.78 on a 1-5 scale), supporting this view.
Supporting evidence includes: (1) forward PE of 9.3x, a 58% discount to the industry average of 22x; (2) revenue growth of 8.8% YoY in Q1 2026, with accelerating multi-quarter trends; (3) operating margin expansion from 22.3% to 24.8% over the last two quarters; and (4) TTM free cash flow of $1.71 billion, providing a strong cash generation profile. The PS ratio of 3.4x is below the industry average of 5x, further supporting the valuation case.
Risks include the aggressive earnings growth expectations (EPS of $9.95 vs. trailing $2.59), the stock's persistent downtrend, and the high debt-to-equity ratio. This Buy rating would be downgraded to Hold if revenue growth decelerates below 5% or if forward PE expands above 15x without corresponding earnings beats. The stock appears undervalued relative to its forward earnings potential but fairly valued on a trailing basis, making it a value play with growth characteristics.
Sign up to view all
SSNC 12-Month Price Forecast
The AI assessment is bullish with medium confidence. The fundamental picture is strong: revenue is growing, margins are expanding, and free cash flow is robust. The forward valuation is deeply discounted, suggesting the market is overly pessimistic about earnings growth. However, the technical downtrend and aggressive EPS expectations introduce uncertainty. The key risk is whether the company can deliver the implied earnings growth. If Q2 2026 results confirm the positive trajectory, the stock could re-rate significantly. The stance would be upgraded to high confidence if the stock breaks above its 50-day moving average and if forward EPS estimates are maintained or raised. Conversely, a downgrade to neutral would occur if revenue growth slips below 5% or if margins contract.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SS&C Technologies's 12-month outlook, with a consensus price target around $92.33 and implied upside of +25.0% versus the current price.
Average Target
$92.33
0 analysts
Implied Upside
+25.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$82 - $112
Analyst target range
SSNC is covered by 9 analysts, with a consensus recommendation of Buy (mean rating 1.78 on a 1-5 scale). The average target price is $93.00, implying 33.7% upside from the current price of $69.56. The distribution shows 8 Buy ratings and 1 Hold (Equal Weight from Morgan Stanley), indicating strong bullish sentiment. The target range spans from $78.00 (low) to $109.00 (high). The high target of $109 assumes successful margin expansion and revenue acceleration from new products and acquisitions, while the low target of $78 reflects risks from integration challenges or slower growth. Recent ratings actions show consistent Buy ratings from DA Davidson, Needham, and UBS, with no downgrades, reinforcing positive sentiment. The wide spread between low and high targets ($31) indicates moderate uncertainty, but the consensus leans heavily bullish. If analyst data were minimal, we would note that limited coverage can lead to higher volatility and less efficient price discovery, but here coverage is adequate.
Bulls vs Bears: SSNC Investment Factors
SSNC presents a compelling value opportunity with strong analyst support, improving margins, and robust free cash flow. The bull case is anchored by a 33.7% upside to the average analyst target and a forward PE that is deeply discounted relative to peers. However, the bear case highlights the stock's persistent downtrend, a trailing PE premium, and aggressive earnings growth expectations that may be unrealistic. The single most important tension is whether the company can deliver the dramatic earnings growth implied by the forward PE—if it does, the stock could re-rate significantly higher; if not, the stock may remain range-bound or decline further. Currently, the evidence leans slightly bullish given the strong fundamental trends and analyst consensus, but the technical weakness warrants caution.
Bullish
- 33.7% Upside to Analyst Target: The average analyst target price of $93.00 implies 33.7% upside from the current price of $69.56. With 8 out of 9 analysts rating it Buy, the consensus is strongly bullish, suggesting the market may be undervaluing the stock.
- Improving Margins and Profitability: Operating margin expanded from 22.3% in Q4 2025 to 24.8% in Q1 2026, while net margin improved from 11.7% to 13.7% over the same period. This margin expansion demonstrates operational leverage and efficient cost management.
- Strong Free Cash Flow Generation: TTM free cash flow stands at $1.71 billion, providing ample liquidity for debt reduction, acquisitions, or shareholder returns. The free cash flow yield is approximately 8% based on the current market cap, which is attractive.
- Forward PE Discount to Peers: The forward PE of 9.3x is a 58% discount to the industry average forward PE of 22x. This suggests the market is pricing in a significant earnings rebound, but if realized, the stock could see substantial multiple expansion.
Bearish
- Trailing PE Premium to Industry: The trailing PE of 26.8x is 22% above the industry average of 22x. This premium may not be justified if earnings growth disappoints, leaving the stock vulnerable to multiple compression.
- Significant Earnings Growth Expectations: The forward PE of 9.3x implies EPS of $9.95, a dramatic increase from trailing EPS of $2.59. This expectation of nearly 4x earnings growth is aggressive and may be difficult to achieve, creating downside risk if results fall short.
- Sustained Downtrend and Underperformance: The stock has declined 16.5% over the past year and is trading near the bottom of its 52-week range. Relative strength versus SPY is -34.8% over one year, indicating persistent underperformance and negative momentum.
- High Debt-to-Equity Ratio: With a debt-to-equity ratio of 1.11, the company carries moderate leverage. While manageable, this debt burden increases financial risk, especially if interest rates remain elevated or cash flows weaken.
SSNC Technical Analysis
SSNC is in a sustained downtrend, with the stock declining 16.5% over the past year and currently trading at $69.56, which is 76.4% of its 52-week range (low $61.40, high $91.07). This positioning near the lower end of the range suggests bearish sentiment and potential value opportunity, but the stock has not yet shown signs of a trend reversal. The 1-year relative strength versus SPY is -34.8%, indicating significant underperformance. Short-term momentum shows a mixed picture: the 1-month price change is +4.8%, while the 3-month change is -3.5%. This divergence—positive short-term momentum within a longer-term downtrend—could signal a potential bottoming process or a temporary bounce. The stock's beta of 1.108 indicates slightly higher volatility than the market, but not extreme. Key support is at the 52-week low of $61.40; a break below that would signal further downside. Resistance is at the 52-week high of $91.07; a breakout above that level would indicate a trend reversal. The stock's 1-month relative strength of +4.5% versus SPY suggests near-term outperformance, but the 3-month relative strength of -8.2% confirms the broader downtrend remains intact.
Beta
—
—
Max Drawdown
-31.2%
Largest decline past year
52-Week Range
$61-$91
Price range past year
Annual Return
-13.9%
Cumulative gain past year
| Period | SSNC Return | S&P 500 |
|---|---|---|
| 1m | +12.0% | +0.8% |
| 3m | +9.8% | +3.5% |
| 6m | -13.4% | +7.2% |
| 1y | -13.9% | +16.5% |
| ytd | -13.8% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SSNC Fundamental Analysis
SSNC's revenue trajectory is growing steadily, with Q1 2026 revenue of $1.647 billion, up 8.8% YoY from $1.514 billion in Q1 2025. The multi-quarter trend shows accelerating growth: Q2 2025 revenue was $1.537 billion, Q3 2025 $1.568 billion, and Q4 2025 $1.654 billion, indicating a consistent upward trajectory. Software-enabled services, which contributed $1.407 billion in Q1 2026, are the primary growth driver, while perpetual licenses remain a small component. The company is profitable, with Q1 2026 net income of $226.1 million and a gross margin of 48.7%. Net margin improved to 13.7% in Q1 2026 from 11.7% in Q4 2025, while operating margin rose to 24.8% from 22.3% over the same period, indicating margin expansion. This is above the industry average for software application companies, reflecting operational leverage. SSNC has a debt-to-equity ratio of 1.11, indicating moderate leverage, and generated free cash flow of $293.7 million in Q1 2026, with TTM free cash flow of $1.71 billion. The company's ROE of 11.6% and ROA of 4.5% suggest efficient capital use. With $3.06 billion in cash at the end of Q1 2026, SSNC has ample liquidity to fund operations and acquisitions, reducing reliance on external financing.
Quarterly Revenue
$1.6B
2026-03
Revenue YoY Growth
+8.8%
YoY Comparison
Gross Margin
48.7%
Latest Quarter
Free Cash Flow
$1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SSNC Overvalued?
Since net income is positive, we lead with the PE ratio. The trailing PE is 26.8x, while the forward PE is 9.3x, a significant gap that implies the market expects substantial earnings growth. The forward PE is based on estimated EPS of $9.95, which would represent a sharp increase from trailing EPS of $2.59 (calculated from net income and shares outstanding). This gap suggests aggressive growth expectations. Compared to the industry average PE of 22x (software application sector), SSNC's trailing PE of 26.8x trades at a 22% premium. However, the forward PE of 9.3x is a 58% discount to the industry forward average, indicating the market is pricing in a dramatic earnings recovery. The PS ratio of 3.4x is below the industry average of 5x, suggesting the stock is not overvalued on a sales basis. Historically, SSNC's trailing PE has ranged from 15.7x (Q4 2022) to 33.8x (Q2 2022). The current 26.8x is near the middle of this range, suggesting valuation is not extreme. The forward PE of 9.3x is well below historical lows, implying the market is pricing in a significant earnings rebound that may not materialize if growth disappoints.
PE
26.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 16x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: SSNC's debt-to-equity ratio of 1.11 indicates moderate leverage, which could strain cash flows if interest rates remain high. The company's net income of $226.1 million in Q1 2026 is solid, but the trailing PE of 26.8x implies the market expects continued growth. Any slowdown in revenue growth (currently 8.8% YoY) or margin contraction could lead to earnings disappointment. Additionally, the company's reliance on acquisitions for growth introduces integration risk and potential goodwill impairment. Free cash flow of $1.71 billion TTM provides a cushion, but debt service costs of $105.4 million in Q1 2026 consume a portion of operating income.
Market & Competitive Risks: The stock's beta of 1.108 indicates slightly higher volatility than the market, making it sensitive to macro downturns. The 1-year relative strength of -34.8% versus SPY shows significant underperformance, which could persist if sector rotation favors other areas. Competitive pressures in financial technology could compress margins or slow organic growth. The stock's current price near the 52-week low of $61.40 suggests bearish sentiment, and a break below that level could trigger further selling. With no recent news to catalyze a reversal, the stock may remain range-bound.
Worst-Case Scenario: If the company fails to meet aggressive earnings expectations (EPS of $9.95 for the forward year), the stock could fall to its 52-week low of $61.40, representing a 11.7% decline from the current price of $69.56. In a severe recession or competitive disruption, the stock could test historical support levels, potentially declining 20-30% to the $50 range. The max drawdown of -31.21% from the 52-week high of $91.07 to the low of $61.40 illustrates the potential downside. An investor could lose approximately 12% to the 52-week low, or more if fundamentals deteriorate.
FAQ
The key risks are: (1) Earnings growth risk: The forward PE of 9.3x implies EPS of $9.95, nearly 4x trailing EPS of $2.59. If the company fails to deliver this growth, the stock could decline significantly. (2) Technical risk: The stock is in a sustained downtrend, down 16.5% over the past year, and trading near its 52-week low of $61.40. A break below that level could trigger further selling. (3) Leverage risk: With a debt-to-equity ratio of 1.11, the company has moderate debt, and rising interest rates could increase interest expenses (Q1 2026 interest expense was $105.4 million). (4) Integration risk: The company's growth strategy relies on acquisitions (e.g., Blue Prism), which carry execution risk and potential goodwill impairment. The most severe risk is the earnings growth shortfall, which could lead to a 12% or more decline to the 52-week low.
The 12-month forecast is cautiously bullish. In the base case (45% probability), the stock reaches the average analyst target of $93.00, a 33.7% gain, driven by steady revenue growth and margin expansion. In the bull case (30% probability), the stock could rise to $109 (56.6% upside) if earnings beat expectations and the market re-rates the stock. In the bear case (25% probability), the stock could fall to $61.40 (11.7% downside) if earnings disappoint. The most likely scenario is the base case, assuming the company delivers on its earnings guidance. The key assumption is that revenue growth remains above 6% and margins continue to improve. Investors should monitor the next earnings report for confirmation of the trend.
SSNC appears undervalued on a forward basis but fairly valued on a trailing basis. The forward PE of 9.3x is a 58% discount to the industry average of 22x, implying the market expects significant earnings growth. The PS ratio of 3.4x is below the industry average of 5x, further suggesting undervaluation on sales. However, the trailing PE of 26.8x is 22% above the industry average, indicating that the stock is not cheap based on past earnings. The PEG ratio of 4.87x suggests the stock is expensive relative to its growth rate, but this metric is distorted by the low trailing EPS. Overall, the valuation implies the market is pricing in a dramatic earnings recovery; if that recovery materializes, the stock is undervalued, but if it disappoints, the stock could be overvalued.
SSNC appears to be a good buy for investors with a medium-term horizon and tolerance for volatility. The stock offers a 33.7% upside to the average analyst target of $93.00, supported by improving margins (operating margin up to 24.8% from 22.3%) and strong free cash flow ($1.71 billion TTM). The forward PE of 9.3x is a 58% discount to the industry average, suggesting the stock is undervalued relative to expected earnings. However, the trailing PE of 26.8x is above the industry average, and the stock is in a sustained downtrend, having fallen 16.5% over the past year. The biggest downside risk is if the company fails to meet aggressive EPS estimates of $9.95, which would likely lead to further price declines. For long-term investors who believe in the earnings growth story, the current price offers an attractive entry point.
SSNC is better suited for medium- to long-term investment rather than short-term trading. The stock's beta of 1.108 indicates slightly higher volatility than the market, but the sustained downtrend and negative momentum make short-term trading risky. The company's growth profile—mid-single-digit revenue growth with improving margins—supports a longer holding period to allow the earnings story to play out. The dividend yield of 1.19% provides a modest income component. Given the forward PE discount and analyst upside, a minimum holding period of 12-18 months is recommended to capture the potential re-rating. Short-term traders may find the stock range-bound and lacking catalysts, while long-term investors can benefit from the value proposition and free cash flow generation.